SO
DFTX

STRS Ohio’s Definium Therapeutics DFTX Stock Holding History

STRS Ohio’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Buy
+19,300
New +$328K ﹤0.01% 1242
2022
Q2 		– Sell
-5,320
Closed -$88K – 2191
2022
Q1 		$88K Hold
5,320
– – ﹤0.01% 1866
2021
Q4 		$110K Hold
5,320
– – ﹤0.01% 1881
2021
Q3 		$185K Buy
5,320
+340
+7% +$14.7K ﹤0.01% 1794
2021
Q2 		$257K Buy
+4,980
New +$261K ﹤0.01% 1748

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's DFTX Position: Q1 2026 in Review

STRS Ohio opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 19,300 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #1242 among its holdings. This is a return to the name: STRS Ohio previously reported a position in DFTX as recently as Q1 2022.

STRS Ohio first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • STRS Ohio held 19,300 shares of Definium Therapeutics worth $365K as of Q1 2026.
  • Definium Therapeutics was a new STRS Ohio position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1242 holding.
  • STRS Ohio first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.